To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Nature Biotechnology 23, 833–838 (1 July 2005) | doi:10.1038/nbt0705-833
John C Lindon , Jeremy K Nicholson , Elaine Holmes , Hector C Keun , Andrew Craig , Jake T M Pearce , Stephen J Bruce , Nigel Hardy , Susanna-Assunta Sansone , Henrik Antti , Par Jonsson , Clare Daykin , Mahendra Navarange , Richard D Beger , Elwin R Verheij , Alexander Amberg , Dorrit Baunsgaard , Glenn H Cantor , Lois Lehman-McKeeman , Mark Earll , Svante Wold , Erik Johansson , John N Haselden , Kerstin Kramer , Craig Thomas , Johann Lindberg , Ina Schuppe-Koistinen , Ian D Wilson , Michael D Reily , Donald G Robertson , Hans Senn , Arno Krotzky , Sunil Kochhar , Jonathan Powell , Frans van der Ouderaa , Robert Plumb , Hartmut Schaefer & Manfred Spraul
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Personal subscribers to Nature Biotechnology can view articles published from 1997 to the current issue. To do this, associate your subscription with your registration via the My Account page. If you already have an active subscription, login here to your nature.com account.
If you do not have access to the article you require, you can purchase the article (see below) or access it through a site license. A site license includes a minimum of four years of archived content; institutions can add additional archived content to their license at any time. Recommend site license access to your institution.
Price: US$32
In order to purchase this article you must be a registered user.
You can also request this document from your local library through inter library loan services.
